RSPH Among Equal Weight ETFs
End-of-day Nov 20, 2026 · 19 Equal weight ETFs by 3Y
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.9% | −5.6% | −2.5% | +2.9% | +22.3% | +26.6% | +47.5% | +30.5% | +173.7% | +772.7% |
| Peer average | −2.3% | −6.8% | −6.2% | −8.1% | +6.7% | +10.7% | +43.9% | +36.7% | +187.2% | — |
| S&P 500 · VOO | −3.4% | −8.3% | −9.5% | −9.2% | +2.2% | +5.5% | +59.8% | +58.7% | +275.8% | — |
$23 of every $1,000 in RSPH is Moderna
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | MRNAModerna | Healthcare | 2.28% | $227.87 | 139K | $27.7M |
| 2 | IDXXIDEXX Laboratories | Healthcare | 2.08% | $208.28 | 37K | $25.3M |
| 3 | MTDMettler-Toledo International | Healthcare | 2.08% | $207.81 | 15K | $25.2M |
| 4 | GEHCGE HealthCare Technologies | Healthcare | 1.94% | $194.35 | 288K | $23.6M |
| 5 | RVTYRevvity | Healthcare | 1.89% | $189.47 | 152K | $23.0M |
| 6 | AAgilent Technologies | Healthcare | 1.88% | $187.64 | 130K | $22.8M |
| 7 | VTRSViatris | Healthcare | 1.86% | $186.47 | 1.1M | $22.6M |
| 8 | EWEdwards Lifesciences | Healthcare | 1.86% | $186.38 | 218K | $22.6M |
| 9 | MCKMcKesson | Healthcare | 1.86% | $185.61 | 21K | $22.5M |
| 10 | BDXBecton Dickinson | Healthcare | 1.83% | $183.49 | 105K | $22.3M |
| 11 | STESteris | Healthcare | 1.83% | $182.90 | 87K | $22.2M |
| 12 | CRLCharles River Laboratories International | Healthcare | 1.83% | $182.69 | 68K | $22.2M |
| 13 | LLYEli Lilly | Healthcare | 1.83% | $182.51 | 16K | $22.2M |
| 14 | WSTWest Pharmaceutical Services | Healthcare | 1.82% | $182.27 | 56K | $22.1M |
| 15 | BIIBBiogen | Healthcare | 1.82% | $181.77 | 89K | $22.1M |
of the $18.6B in 21 Equal weight ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | MRNA | Moderna | 2.28% |
| 2 | IDXX | IDEXX Laboratories | 2.08% |
| 3 | MTD | Mettler-Toledo International | 2.08% |
| 4 | GEHC | GE HealthCare Technologies | 1.94% |
| 5 | RVTY | Revvity | 1.89% |
| 6 | A | Agilent Technologies | 1.88% |
| 7 | VTRS | Viatris | 1.86% |
| 8 | EW | Edwards Lifesciences | 1.86% |
| 9 | MCK | McKesson | 1.86% |
| 10 | BDX | Becton Dickinson & | 1.83% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 21, 2026 | Sep 25, 2026 | $0.0516 |
| Jun 22, 2026 | Jun 26, 2026 | $0.0627 |
| Mar 23, 2026 | Mar 27, 2026 | $0.0561 |
| Dec 22, 2025 | Dec 26, 2025 | $0.0530 |
| Sep 22, 2025 | Sep 26, 2025 | $0.0599 |
| Jun 23, 2025 | Jun 27, 2025 | $0.0555 |
| Mar 24, 2025 | Mar 28, 2025 | $0.0551 |
| Dec 23, 2024 | Dec 27, 2024 | $0.0569 |
| Sep 23, 2024 | Sep 27, 2024 | $0.0547 |
| Jun 24, 2024 | Jun 28, 2024 | $0.0508 |
| Mar 18, 2024 | Mar 22, 2024 | $0.0459 |
| Dec 18, 2023 | Dec 22, 2023 | $0.0499 |